| Literature DB >> 25411232 |
Inge Seim1, Siming Ma1, Xuming Zhou1, Maxim V Gerashchenko1, Sang-Goo Lee1, Robert Suydam2, John C George2, John W Bickham3, Vadim N Gladyshev1.
Abstract
Mammals vary dramatically in lifespan, by at least two-orders of magnitude, but the molecular basis for this difference remains largely unknown. The bowhead whale Balaena mysticetus is the longest-lived mammal known, with an estimated maximal lifespan in excess of two hundred years. It is also one of the two largest animals and the most cold-adapted baleen whale species. Here, we report the first genome-wide gene expression analyses of the bowhead whale, based on the de novo assembly of its transcriptome. Bowhead whale or cetacean-specific changes in gene expression were identified in the liver, kidney and heart, and complemented with analyses of positively selected genes. Changes associated with altered insulin signaling and other gene expression patterns could help explain the remarkable longevity of bowhead whales as well as their adaptation to a lipid-rich diet. The data also reveal parallels in candidate longevity adaptations of the bowhead whale, naked mole rat and Brandt's bat. The bowhead whale transcriptome is a valuable resource for the study of this remarkable animal, including the evolution of longevity and its important correlates such as resistance to cancer and other diseases.Entities:
Mesh:
Year: 2014 PMID: 25411232 PMCID: PMC4247388 DOI: 10.18632/aging.100699
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
Figure 1The bowhead whale and overview of its geographic range
(A) Bowhead whale (Balaena mysticetus). Reproduced courtesy of Encyclopaedia Britannica, Inc., copyright 2002. Human and elephant are shown for size comparison. (B) Occurrence of B. mysticetus in Arctic waters. The site of sample collection (Barrow, Alaska) is shown as a red dot.
Figure 2Overview of orthologous genes shared between the bowhead whale and other mammals and the phylogenetic position of the bowhead whale
(A) Venn diagram showing the number of common and unique orthologs identified in the liver, kidney and heart. (B) Estimation of divergence time using phylogenetic analysis of 10 species based on 6,998 orthologous genes from the liver. Triangle arrows and the numbers above denote the most recent common ancestor (MRCA), and the scale units are million years ago. The standard error range for each divergence time is represented by a dashed line. The red solid circles on the branch nodes denote the node as an ‘age constraint’ used in the estimation of the time of divergence.
Figure 3Heat map displaying 45 genes differentially expressed in the bowhead whale liver
Genes with ≥2 log2-fold change and with a Benjamini–Hochberg false discovery rate ≤ 0.05) are shown. The color scheme was used wherein the gradient of red indicates decreased expression, and blue increased expression. Selected genes discussed in the text are highlighted. Hierarchical clustering of samples was based on Pearson's correlation of gene expression data.
Genes differentially expressed in the liver of bowhead whales compared to other mammals
For each gene, gene counts were normalized across all replicates. We used an absolute value of log2 Ratio≥2, a Benjamini-Hochberg corrected P-value≤ 0.05, and a B-value of at least 2.945 (representing a 95% probability that a gene is differentially expressed) as the threshold to judge the significance of gene expression difference between the bowhead whale and other mammals. A negative fold change denotes a higher gene expression compared to the other mammals examined, and vice versa.
| Gene symbol (mouse) | Ensembl transcript ID | Name | logFC | P-value | BH-adj. P-value | B-value |
|---|---|---|---|---|---|---|
| ENSMUST00000102891 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif | −3.84 | 5.55E-006 | 8.95E-004 | 4.06 | |
| ENSMUST00000042944 | ArfGAP with RhoGAP domain | −2.40 | 9.01E-007 | 1.96E-004 | 5.81 | |
| ENSMUST00000006435 | ATPase | 2.94 | 1.42E-008 | 1.34E-005 | 9.66 | |
| ENSMUST00000048788 | cDNA sequence BC027231 | −3.12 | 6.29E-007 | 1.61E-004 | 6.15 | |
| ENSMUST00000033741 | biglycan | −2.45 | 8.00E-006 | 1.13E-003 | 3.70 | |
| ENSMUST00000164826 | caspase recruitment domain family | −3.61 | 2.61E-007 | 8.67E-005 | 7.00 | |
| ENSMUST00000038107 | Cbp/p300-interacting transactivator | −3.08 | 1.14E-005 | 1.37E-003 | 3.37 | |
| ENSMUST00000088778 | CAAX box 1B | −3.87 | 3.26E-007 | 9.67E-005 | 6.78 | |
| ENSMUST00000032908 | cytochrome P450 | 3.42 | 5.80E-007 | 1.56E-004 | 6.21 | |
| ENSMUST00000028917 | D-tyrosyl-tRNA deacylase 1 | −2.16 | 6.96E-007 | 1.64E-004 | 6.06 | |
| ENSMUST00000044622 | ectopic P-granules autophagy protein 5 homolog (C. elegans) | −4.10 | 2.70E-006 | 5.26E-004 | 4.76 | |
| ENSMUST00000006614 | Eph receptor A2 | −2.76 | 5.78E-006 | 8.98E-004 | 4.03 | |
| ENSMUST00000028135 | family with sequence similarity 129 | −2.97 | 3.10E-007 | 9.67E-005 | 6.83 | |
| ENSMUST00000108285 | family with sequence similarity 92 | 2.96 | 6.59E-007 | 1.62E-004 | 6.09 | |
| ENSMUST00000021603 | fibulin 5 | −4.57 | 5.76E-008 | 4.65E-005 | 8.43 | |
| ENSMUST00000028252 | growth factor receptor bound protein 14 | 5.21 | 4.61E-009 | 5.20E-006 | 10.73 | |
| ENSMUST00000112923 | intraflagellar transport 122 | −3.02 | 6.41E-006 | 9.52E-004 | 3.93 | |
| ENSMUST00000087033 | immunoglobulin joining chain | −3.30 | 9.15E-006 | 1.20E-003 | 3.59 | |
| ENSMUST00000059155 | insulin induced gene 1 | 3.04 | 8.94E-006 | 1.20E-003 | 3.63 | |
| ENSMUST00000018212 | integrator complex subunit 2 | −2.85 | 5.89E-006 | 8.98E-004 | 4.01 | |
| ENSMUST00000189881 | IQ motif and Sec7 domain 1 | 5.16 | 2.00E-007 | 7.52E-005 | 7.22 | |
| ENSMUST00000142734 | lectin | −3.58 | 1.15E-007 | 6.48E-005 | 7.78 | |
| ENSMUST00000035078 | leucine rich repeat (in FLII) interacting protein 2 | 2.61 | 2.52E-007 | 8.67E-005 | 6.99 | |
| ENSMUST00000052060 | mannan-binding lectin serine peptidase 2 | 3.46 | 2.63E-009 | 4.94E-006 | 11.32 | |
| ENSMUST00000156481 | mediator complex subunit 28 | 3.16 | 1.93E-006 | 3.89E-004 | 5.08 | |
| ENSMUST00000021368 | nuclear export mediator factor | 3.48 | 3.17E-006 | 5.77E-004 | 4.61 | |
| ENSMUST00000068681 | neuronal guanine nucleotide exchange factor | 5.16 | 1.26E-007 | 6.48E-005 | 7.65 | |
| ENSMUST00000030834 | nitric oxide synthase 3 | −3.58 | 7.94E-006 | 1.13E-003 | 3.72 | |
| ENSMUST00000030872 | origin recognition complex | 2.69 | 1.92E-006 | 3.89E-004 | 5.09 | |
| ENSMUST00000115274 | platelet derived growth factor receptor | −4.44 | 3.62E-006 | 6.38E-004 | 4.48 | |
| ENSMUST00000019998 | PERP | 4.91 | 6.10E-010 | 3.44E-006 | 12.57 | |
| ENSMUST00000170392 | peptidoglycan recognition protein 2 | 6.23 | 1.25E-009 | 3.52E-006 | 11.93 | |
| ENSMUST00000057927 | Ras interacting protein 1 | −4.69 | 9.75E-008 | 6.11E-005 | 7.94 | |
| ENSMUST00000022428 | ribonuclease | 3.21 | 3.60E-007 | 1.01E-004 | 6.69 | |
| ENSMUST00000102561 | replication protein A2 | −2.42 | 2.87E-006 | 5.41E-004 | 4.70 | |
| ENSMUST00000034543 | RNA pseudouridylate synthase domain containing 4 | −4.13 | 1.84E-007 | 7.52E-005 | 7.33 | |
| ENSMUST00000035106 | solute carrier family 25 | 2.90 | 8.36E-007 | 1.89E-004 | 5.87 | |
| ENSMUST00000168423 | SMAD family member 2 | 2.12 | 1.58E-005 | 1.81E-003 | 3.09 | |
| ENSMUST00000049908 | single stranded DNA binding protein 4 | −2.50 | 8.39E-006 | 1.15E-003 | 3.68 | |
| ENSMUST00000047421 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | −3.79 | 8.04E-008 | 5.67E-005 | 8.12 | |
| ENSMUST00000017610 | tissue inhibitor of metalloproteinase 2 | −5.09 | 3.71E-009 | 5.20E-006 | 11.02 | |
| ENSMUST00000109468 | topoisomerase (DNA) I | 2.18 | 1.07E-005 | 1.35E-003 | 3.45 | |
| ENSMUST00000034190 | Vac14 homolog (S. cerevisiae) | −2.27 | 1.87E-007 | 7.52E-005 | 7.32 | |
| ENSMUST00000017821 | WD repeat and SOCS box-containing 1 | −4.40 | 1.57E-007 | 7.40E-005 | 7.48 | |
| ENSMUST00000084727 | zinc finger protein 143 | −2.43 | 5.19E-006 | 8.62E-004 | 4.13 |
Enrichment of biological process (BP) Gene Ontology (GO) terms for genes differentially expressed in the bowhead liver compared to other mammals
| GO Category | Term | Count | Genes | Fold Enrichment | Fisher's exact P-value |
|---|---|---|---|---|---|
| GO:0001501 | skeletal system development | 4 | 7.3 | 2.00E-003 | |
| GO:0048568 | embryonic organ development | 3 | 7.4 | 7.20E-003 | |
| GO:0006260 | DNA replication | 3 | 6.1 | 1.30E-002 | |
| GO:0040013 | negative regulation of locomotion | 2 | 22.1 | 3.50E-003 | |
| GO:0030336 | negative regulation of cell migration | 2 | 22.1 | 3.50E-003 | |
| GO:0001570 | vasculogenesis | 2 | 20.6 | 4.00E-003 | |
| GO:0051271 | negative regulation of cell motion | 2 | 19.2 | 4.60E-003 |
Figure 4Boxplots of selected genes differentially expressed in the bowhead whale liver
(A) Growth factor receptor bound protein 14 (Grb14). (B) Insulin induced gene 1 (Insig1). (C) Cbp/p300-interacting transactivator (Cited2). (D) TP53 Apoptosis Effector (Perp). Genes were subjected to limma analysis at 5% FDR and 2.0 fold-change cut-off. Normalized log2 read counts and P-values adjusted for multiple comparisons (Benjamini and Hochberg) are shown.
Genes differentially expressed in the bowhead and minke whale heart compared to other mammals
For each gene, gene counts were normalized across all replicates. We used an absolute value of log2 Ratio≥2, a Benjamini-Hochberg corrected P-value≤ 0.05, and a B-value of at least 2.945 (representing a 95% probability that a gene is differentially expressed) as the threshold to judge the significance of gene expression difference between whales and other mammals. A negative fold change denotes a higher gene expression compared to the other mammals examined, and vice versa.
| Gene symbol (mouse) | Ensembl transcript ID | Name | logFC | P-value | BH-adj. P-value | B-value |
|---|---|---|---|---|---|---|
| Asl | ENSMUST00000161094 | argininosuccinate lyase | −4.40 | 1.43E-005 | 1.50E-002 | 3.19 |
| Brk1 | ENSMUST00000035725 | BRICK1, SCAR/WAVE actin-nucleating complex subunit | −2.85 | 5.69E-006 | 7.93E-003 | 3.96 |
| Eif3l | ENSMUST00000040518 | eukaryotic translation initiation factor 3, subunit L | −2.46 | 2.28E-006 | 4.77E-003 | 4.95 |
| Htatip2 | ENSMUST00000085272 | HIV-1 tat interactive protein 2, homolog (human) | −6.00 | 1.40E-007 | 5.87E-004 | 6.99 |
Proteins with unique amino acids in the bowhead whale compared to 67 vertebrates
AA changes correspond to residue locations in the translated human RefSeq mRNA entry (typically the longest RefSeq entry of each gene). Genes shown in bold were checked by BLAST analysis of raw sequence data. Some of the genes in this table, especially those not shown in bold, may be false-positives.
| Gene name | Symbol (human) | RefSeq ID | AA change(s) |
|---|---|---|---|
| actin-binding Rho activating protein | NM_139166 | HKR283P | |
| adaptor-related protein complex 3, beta 1 subunit | NM_003664 | R1086Q | |
| annexin A7 | NM_001156 | Y410C | |
| arachidonate 5-lipoxygenase | NM_000698 | D204N | |
| calcium homeostasis modulator 2 | NM_015916 | F172C | |
| calsyntenin 2 | NM_022131 | Q362H | |
| cell division cycle associated 7 | NM_145810 | ED257K | |
| ClpB caseinolytic peptidase B homolog (E. coli) | NM_001258392 | HR226W | |
| complement component 5 | NM_001735 | I760K | |
| cytidine and dCMP deaminase domain containing 1 | NM_030911 | YQ367C | |
| derlin 1 | NM_024295 | R197G | |
| enhancer of polycomb homolog 1 (Drosophila) | NM_001272004 | G562R | |
| erythrocyte membrane protein band 4.1-like 1 | NM_001258329 | K478M | |
| fucose-1-phosphate guanylyltransferase | NM_003838 | HK339E | |
| gem (nuclear organelle) associated protein 4 | NM_015721 | KR721T | |
| gigaxonin | NM_022041 | E74V | |
| glutamate receptor, ionotropic, kainate 2 | NM_175768 | Y571C, Q621R | |
| glutamate receptor, metabotropic 1 | NM_001278066 | E559D | |
| heat shock protein 90kDa alpha (cytosolic), class B member 1 | NM_001271971 | H121T | |
| homeodomain interacting protein kinase 1 | NM_181358 | SP465C | |
| homeodomain interacting protein kinase 3 | NM_005734 | Q698H | |
| ligase III, DNA, ATP-dependent | NM_013975 | D255N | |
| mitogen-activated protein kinase kinase kinase 7 | NM_145331 | V424D | |
| Nance-Horan syndrome (congenital cataracts and dental anomalies) | NM_001291868 | R388Q | |
| NEDD4 binding protein 3 | NM_015111 | Q384H | |
| neuronal pentraxin II | NM_002523 | Q375H | |
| NOP2 nucleolar protein | NM_001258310 | YF516C | |
| NRDE-2, necessary for RNA interference, domain containing | NM_017970 | H592Q | |
| nuclear receptor coactivator 2 | NM_006540 | F441C | |
| nuclear receptor coactivator 7 | NM_181782 | SAT160D | |
| nucleolar protein 6 (RNA-associated) | NM_022917 | R582L | |
| oncoprotein induced transcript 3 | NM_152635 | P353R | |
| oxidative stress induced growth inhibitor family member 2 | NM_004337 | ED194K | |
| PALM2-AKAP2 readthrough | NM_147150 | ED488G | |
| patched 1 | NM_000264 | S1185C | |
| phosphodiesterase 4D interacting protein | NM_001002811 | SGNTP264R | |
| polymerase (DNA-directed), delta interacting protein 3 | NM_032311 | Q198R | |
| potassium voltage-gated channel, Shal-related subfamily, member 2 | NM_012281 | L457R | |
| protein kinase, cAMP-dependent, regulatory, type I, alpha | NM_212472 | N26D | |
| protocadherin alpha subfamily C, 2 | NM_018899 | K884Q | |
| serpin peptidase inhibitor, clade C (antithrombin), member 1 | NM_000488 | E359D | |
| striatin, calmodulin binding protein | NM_003162 | ED279V | |
| transmembrane protein 214 | NM_017727 | R251Q | |
| transmembrane protein 25 | NM_032780 | G162D | |
| tripartite motif containing 29 | NM_012101 | Q250H | |
| tyrosine aminotransferase | NM_000353 | Y442H | |
| vacuolar protein sorting 13 homolog B (yeast) | NM_015243 | G567R |
Figure 5Evolution of vertebrate VEGFD protein sequences
(A) Alignment of vertebrate VEGFD protein sequences. VEGFD residues at the VEGFR-2 receptor-ligand interface are highlighted in yellow, highly conserved cysteine residues that stabilize VEGFD in orange, and a radical amino acid in the bowhead whale, but not in 67 other species, is shown in red. (B) Modeled VEGFD structure. Location of the unique arginine residue in the bowhead whale protein is shown.
Genes differentially expressed in the kidney of bowhead whales compared to other mammals
For each gene, gene counts were normalized across all replicates. We used an absolute value of log2 Ratio≥2, Benjamini-Hochberg corrected P-value≤ 0.05 a B-value of at least 2.945 (representing a 95% probability that a gene is differentially expressed) as the threshold to judge the significance of gene expression difference between the bowhead whale and other mammals. A negative fold change denotes a higher gene expression compared to the other mammals examined, and vice versa.
| Gene symbol (mouse) | Ensembl transcript ID | Name | logFC | P-value | BH-adj. P-value | B-value |
|---|---|---|---|---|---|---|
| ENSMUST00000023610 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 | −2.08 | 2.6E-07 | 1.0E-04 | 6.98 | |
| ENSMUST00000035719 | ankyrin repeat domain 6 | −3.37 | 2.5E-06 | 3.2E-04 | 4.84 | |
| ENSMUST00000006618 | Rho guanine nucleotide exchange factor (GEF) 19 | −3.41 | 2.9E-07 | 1.0E-04 | 6.89 | |
| ENSMUST00000025893 | ADP-ribosylation factor-like 2 | −2.36 | 1.2E-06 | 2.2E-04 | 5.52 | |
| ENSMUST00000185641 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9) | −2.22 | 8.6E-07 | 1.8E-04 | 5.83 | |
| ENSMUST00000080797 | cadherin 3 | −3.41 | 7.6E-06 | 6.6E-04 | 3.73 | |
| ENSMUST00000057037 | centrosomal protein 170 | −2.71 | 1.5E-06 | 2.3E-04 | 5.36 | |
| ENSMUST00000030901 | cleavage and polyadenylation specific factor 3-like | −2.44 | 3.3E-06 | 3.9E-04 | 4.52 | |
| ENSMUST00000088778 | CAAX box 1B | −2.29 | 1.6E-06 | 2.3E-04 | 5.25 | |
| ENSMUST00000098914 | DENN/MADD domain containing 4B | −2.68 | 2.3E-06 | 3.0E-04 | 4.92 | |
| ENSMUST00000056032 | E4F transcription factor 1 | −2.08 | 1.7E-05 | 1.1E-03 | 2.99 | |
| ENSMUST00000064795 | early growth response 1 | −4.04 | 2.2E-07 | 9.4E-05 | 7.16 | |
| ENSMUST00000053748 | erythrocyte protein band 4.1-like 2 | −2.41 | 2.2E-08 | 2.0E-05 | 9.36 | |
| ENSMUST00000030165 | Fanconi anemia, complementation group G | −3.22 | 1.0E-05 | 7.6E-04 | 3.51 | |
| ENSMUST00000045737 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 | 2.33 | 7.9E-06 | 6.6E-04 | 3.69 | |
| ENSMUST00000053753 | gap junction protein, alpha 4 | −3.17 | 7.3E-08 | 4.8E-05 | 8.21 | |
| ENSMUST00000044158 | glioma tumor suppressor candidate region gene 2 | −2.60 | 2.2E-08 | 2.0E-05 | 9.40 | |
| ENSMUST00000041736 | histone deacetylase 11 | −2.01 | 8.3E-07 | 1.8E-04 | 5.89 | |
| ENSMUST00000059270 | HEAT repeat containing 1 | 2.60 | 1.2E-06 | 2.2E-04 | 5.47 | |
| ENSMUST00000120904 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 | −2.62 | 7.8E-07 | 1.8E-04 | 5.94 | |
| ENSMUST00000048794 | homeobox A5 | −3.44 | 7.9E-06 | 6.6E-04 | 3.73 | |
| ENSMUST00000023478 | immunoglobulin superfamily, member 11 | 4.09 | 9.2E-07 | 1.9E-04 | 5.72 | |
| ENSMUST00000064922 | jun B proto-oncogene | −3.44 | 1.5E-06 | 2.3E-04 | 5.29 | |
| ENSMUST00000036884 | Kruppel-like factor 9 | 2.26 | 9.3E-06 | 7.2E-04 | 3.60 | |
| ENSMUST00000177588 | ligase I, DNA, ATP-dependent | −2.50 | 9.3E-06 | 7.2E-04 | 3.54 | |
| ENSMUST00000113822 | leucine rich repeat and fibronectin type III domain containing 4 | −2.78 | 5.0E-07 | 1.4E-04 | 6.37 | |
| ENSMUST00000068725 | mitochondrial amidoxime reducing component 2 | 5.01 | 2.6E-07 | 1.0E-04 | 6.90 | |
| ENSMUST00000043848 | non-SMC condensin I complex, subunit D2 | −2.14 | 1.3E-08 | 1.5E-05 | 9.91 | |
| ENSMUST00000000199 | neuronal calcium sensor 1 | −2.40 | 8.7E-07 | 1.8E-04 | 5.84 | |
| ENSMUST00000046719 | nuclear transcription factor-Y alpha | 3.45 | 2.2E-07 | 9.4E-05 | 7.02 | |
| ENSMUST00000015391 | nipsnap homolog 3B (C. elegans) | −2.47 | 5.0E-06 | 5.0E-04 | 4.18 | |
| ENSMUST00000103213 | notchless homolog 1 (Drosophila) | −3.32 | 7.1E-10 | 2.6E-06 | 12.57 | |
| ENSMUST00000035053 | NME/NM23 nucleoside diphosphate kinase 6 | 2.34 | 4.7E-07 | 1.4E-04 | 6.30 | |
| ENSMUST00000023779 | nuclear receptor subfamily 4, group A, member 1 | −5.09 | 1.5E-07 | 7.7E-05 | 7.53 | |
| ENSMUST00000121785 | palladin, cytoskeletal associated protein | 4.13 | 7.0E-09 | 1.3E-05 | 10.13 | |
| ENSMUST00000056370 | polyamine-modulated factor 1 | −2.39 | 8.1E-06 | 6.7E-04 | 3.72 | |
| ENSMUST00000061850 | protein-O-mannose kinase | −2.21 | 1.0E-06 | 2.0E-04 | 5.72 | |
| ENSMUST00000005651 | P450 (cytochrome) oxidoreductase | 2.49 | 4.8E-06 | 5.0E-04 | 4.18 | |
| ENSMUST00000021942 | PRELI domain containing 1 | 2.72 | 1.4E-07 | 7.7E-05 | 7.56 | |
| ENSMUST00000047040 | protein kinase C, delta binding protein | −3.03 | 1.6E-06 | 2.3E-04 | 5.25 | |
| ENSMUST00000031531 | proteasome (prosome, macropain) assembly chaperone 3 | −2.12 | 3.8E-06 | 4.3E-04 | 4.43 | |
| ENSMUST00000102561 | replication protein A2 | −2.61 | 1.2E-08 | 1.5E-05 | 9.95 | |
| ENSMUST00000008826 | ribosomal protein L10 | −2.37 | 7.7E-07 | 1.8E-04 | 5.93 | |
| ENSMUST00000080813 | ribosomal protein S17 | −2.34 | 1.1E-05 | 7.9E-04 | 3.33 | |
| ENSMUST00000024005 | secretogranin V | −2.81 | 6.8E-07 | 1.7E-04 | 6.07 | |
| ENSMUST00000114991 | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C | −2.55 | 1.4E-07 | 7.7E-05 | 7.58 | |
| ENSMUST00000034467 | SprT-like N-terminal domain | −2.14 | 1.6E-06 | 2.3E-04 | 5.25 | |
| ENSMUST00000081635 | suppression of tumorigenicity 7 | 2.56 | 9.5E-06 | 7.3E-04 | 3.58 | |
| ENSMUST00000030622 | SYF2 homolog, RNA splicing factor (S. cerevisiae) | 2.03 | 1.2E-05 | 8.6E-04 | 3.33 | |
| ENSMUST00000146358 | transducin-like enhancer of split 2, homolog of Drosophila E(spl) | −2.60 | 1.6E-06 | 2.3E-04 | 5.25 | |
| ENSMUST00000172159 | TNF receptor-associated factor 1 | −3.11 | 1.2E-06 | 2.2E-04 | 5.56 | |
| ENSMUST00000089302 | ubiquitin specific peptidase 9, X chromosome | 5.60 | 5.1E-11 | 3.7E-07 | 14.39 | |
| ENSMUST00000044286 | zinc finger, DHHC domain containing 1 | −2.16 | 3.7E-09 | 8.9E-06 | 11.09 |
Enrichment of biological process (BP) Gene Ontology (GO) terms for genes differentially expressed in the kidney of bowhead whales compared to other mammals
| GO Category | Term | Count | Genes | Fold Enrichment | Fisher's exact P-value |
|---|---|---|---|---|---|
| GO:0000087 | M phase of mitotic cell cycle | 8 | 6.1 | 3.80E-003 | |
| GO:0007067 | mitosis | 8 | 6.1 | 3.80E-003 | |
| GO:0000280 | nuclear division | 8 | 6.1 | 3.80E-003 | |
| GO:0006350 | transcription | 20 | 2.2 | 1.10E-002 | |
| GO:0048285 | organelle fission | 8 | 5.9 | 4.40E-003 | |
| GO:0000279 | M phase | 8 | 4.9 | 8.40E-003 | |
| GO:0000278 | mitotic cell cycle | 8 | 4.8 | 8.80E-003 | |
| GO:0022403 | cell cycle phase | 8 | 4.2 | 1.40E-002 | |
| GO:0051301 | cell division | 8 | 4.1 | 1.60E-002 | |
| GO:0001825 | blastocyst formation | 4 | 24.7 | 2.80E-003 | |
| GO:0045449 | regulation of transcription | 20 | 1.8 | 4.00E-002 |
Positively selected genes in the bowhead whale
| Gene symbol (mouse) | Ensembl transcript ID | Gene description |
|---|---|---|
| ENSMUST00000046743 | quinone oxidoreductase-like protein 2-like | |
| ENSMUST00000032629 | cytoplasmic FMR1 interacting protein 1 | |
| ENSMUST00000117507 | extracellular matrix protein 1 | |
| ENSMUST00000071739 | glycogen synthase kinase 3 alpha | |
| ENSMUST00000059042 | general transcription factor II I | |
| ENSMUST00000074898 | haptoglobin | |
| ENSMUST00000059115 | mitochondrial tumor suppressor 1 | |
| ENSMUST00000015855 | prune exopolyphosphatase |